• Home
• Study Overview
• Eligibility Criteria
• Study Team
• Study Background
• Study Publications
• References
• Study Sponsors
• Related Links
• Contacts

Study Overview

Our Goal:

Neurobehavioral deficits have been observed in both animal and epidemiologic studies of in utero exposures to polychlorinated biphenyls (PCBs). Immunologic toxicity of dioxin and several congeners of PCBs have been observed in animals, but human data for adults have provided little support.

The goal of our study is to examine PCBs, 2,3,7,8-tetrachlorinated dibenzo-dioxin (TCDD), and dioxin-like toxic equivalence (TEQ) exposures in relation to neurobehavioral and immunologic development in children.

How the study is being conducted:

The study will involve a cohort of births from two districts in eastern Slovakia: one is Michalovce, where a chemical manufacturing plant that operated from 1959 through the mid-1980s improperly discharged large quantities of contaminated waste into the surrounding area; the other is Svidnik, a comparative region without direct exposure to this pollution.

A total of 1200 mother-child pairs will be enrolled into the study. The distributions of PCB congeners in umbilical cord and maternal serum collected at birth, and in infant serum from 6 and 16 months of age. Metabolites of PCBs will be measured in maternal serum. These determinants will be examined in relation to immunophenotypes of lymphocytes, thymic size, post-vaccination antibody titers, immunoglobulins, hearing, motor and cognitive impairment, childhood morbidity, prenatal and postnatal growth, and thyroid hormones in early life.

University of California, Davis - Department of Epidemiology and Preventive Medicine - TB 168 - Davis, CA 95616